KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Tenet Healthcare (THC) EBIAT (2016 - 2025)

Tenet Healthcare's EBIAT history spans 17 years, with the latest figure at $644.0 million for Q4 2025.

  • For Q4 2025, EBIAT rose 12.59% year-over-year to $644.0 million; the TTM value through Dec 2025 reached $2.4 billion, down 41.76%, while the annual FY2025 figure was $2.4 billion, 41.76% down from the prior year.
  • EBIAT for Q4 2025 was $644.0 million at Tenet Healthcare, up from $579.0 million in the prior quarter.
  • Across five years, EBIAT topped out at $2.3 billion in Q1 2024 and bottomed at -$151.0 million in Q3 2022.
  • The 5-year median for EBIAT is $466.5 million (2023), against an average of $474.6 million.
  • The largest annual shift saw EBIAT plummeted 126.12% in 2022 before it skyrocketed 688.51% in 2024.
  • A 5-year view of EBIAT shows it stood at -$142.0 million in 2021, then surged by 588.03% to $693.0 million in 2022, then plummeted by 34.2% to $456.0 million in 2023, then grew by 25.44% to $572.0 million in 2024, then increased by 12.59% to $644.0 million in 2025.
  • Per Business Quant, the three most recent readings for THC's EBIAT are $644.0 million (Q4 2025), $579.0 million (Q3 2025), and $522.0 million (Q2 2025).